Defining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic Neuritis



Status:Recruiting
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:November 2013
End Date:December 2016

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Potential Neuroprotection With ACTHAR Following Acute Optic Neuritis

The goal of the study is to determine the earliest structural changes in the optic nerve
during the acute event and during the twelve months of recovery following Acthar treatment.

Determine the earliest structural changes in the optic nerve during the acute event and
during the twelve months of recovery following Acthar treatment.

Inclusion Criteria:

- unilateral acute demyelinating optic neuritis

- Able to provide informed consent

- age 18 or older

- can perform the above listed electrophysiologic diagnostic testing

- can perform high and low contrast visual acuity and visual field perimetry

Exclusion Criteria:

- prior diagnosis of remitting/relapsing multiple sclerosis(RRMS)

- secondary progressive MS(SPMS)

- primary progressive MS (PPMS)

- undergoing treatment with medications approve for treatment of RRMS(except
corticosteroids for a condition not involving central nervous system demyelination)

- prior diagnosis of systemic lupus erythematosis

- mixed connective tissue disease

- vasculitis

- sarcoidosis

- neuro-myelitis optica
We found this trial at
1
site
Neuro-Ophthalmologic Associates, PC
Philadelphia, Pennsylvania 19107
Principal Investigator: Robert C Sergott, M.D.
Phone: 215-825-4725
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials